Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Szabo

Showing results (11-20 of 221) with videos related to

Pageof 23
Sort By:
Oral Oncology|January 18, 2014
PPARγ in head and neck cancer preventionMauricio Burotto, Eva Szabo
Cancer Journal (Sudbury, Mass.)|September 23, 2024
Repurposing Drugs for Cancer Prevention: Targeting Mechanisms Common to Chronic DiseasesNirmal Choradia, Eva Szabo
The New England Journal of Medicine|April 25, 2014
Images in clinical medicine. Sunitinib-associated hair depigmentationChristina Brzezniak, Eva Szabo
American Journal of Respiratory and Critical Care Medicine|December 17, 2015
Preinvasive Endobronchial Lesions: Lung Cancer Precursors and Risk Markers?Stephen Lam, Eva Szabo
Journal of the National Cancer Institute|February 6, 2003
Predicting success in cancer prevention trialsJason S Vourlekis, Eva Szabo
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
Enhanced growth inhibition by combination differentiation therapy with ligands of peroxisome proliferator-activated receptor-gamma and inhibitors of histone deacetylase in adenocarcinoma of the lungTsg-Hui Chang, Eva Szabo
Cancer Prevention Research (Philadelphia, Pa.)|January 10, 2014
Fifty years of tobacco carcinogenesis research: from mechanisms to early detection and prevention of lung cancerStephen S Hecht, Eva Szabo
Current Topics in Medicinal Chemistry|February 17, 2016
Repurposing Drugs for Cancer PreventionDaniel K Lee, Eva Szabo
Disease Markers|August 24, 2004
Use of markers for the detection and treatment of lung cancerJason S Vourlekis, Eva Szabo
Cancer Prevention Research (Philadelphia, Pa.)|August 23, 2012
Validation of LOH profiles for assessing oral cancer riskMark W Lingen, Eva Szabo
Pageof 23

Showing results (11-20 of 221) with videos related to

Sort By:
Pageof 23
Oral Oncology|January 18, 2014
PPARγ in head and neck cancer preventionMauricio Burotto, Eva Szabo
Cancer Journal (Sudbury, Mass.)|September 23, 2024
Repurposing Drugs for Cancer Prevention: Targeting Mechanisms Common to Chronic DiseasesNirmal Choradia, Eva Szabo
The New England Journal of Medicine|April 25, 2014
Images in clinical medicine. Sunitinib-associated hair depigmentationChristina Brzezniak, Eva Szabo
American Journal of Respiratory and Critical Care Medicine|December 17, 2015
Preinvasive Endobronchial Lesions: Lung Cancer Precursors and Risk Markers?Stephen Lam, Eva Szabo
Journal of the National Cancer Institute|February 6, 2003
Predicting success in cancer prevention trialsJason S Vourlekis, Eva Szabo
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
Enhanced growth inhibition by combination differentiation therapy with ligands of peroxisome proliferator-activated receptor-gamma and inhibitors of histone deacetylase in adenocarcinoma of the lungTsg-Hui Chang, Eva Szabo
Cancer Prevention Research (Philadelphia, Pa.)|January 10, 2014
Fifty years of tobacco carcinogenesis research: from mechanisms to early detection and prevention of lung cancerStephen S Hecht, Eva Szabo
Current Topics in Medicinal Chemistry|February 17, 2016
Repurposing Drugs for Cancer PreventionDaniel K Lee, Eva Szabo
Disease Markers|August 24, 2004
Use of markers for the detection and treatment of lung cancerJason S Vourlekis, Eva Szabo
Cancer Prevention Research (Philadelphia, Pa.)|August 23, 2012
Validation of LOH profiles for assessing oral cancer riskMark W Lingen, Eva Szabo
Pageof 23